← Back to headlines
Psyence BioMed Welcomes US Executive Action on Ibogaine Research
Psyence BioMed has expressed its support for recent U.S. executive action aimed at advancing research into Ibogaine.
17 Apr, 13:15 — 17 Apr, 13:15
Sources
Showing 1 of 1 sources
Related Stories
Trump Considers Military Action Against Iran Amid Hormuz Blockade Discussions; UK Declines to Join
just now
Zaanstad Attempts to Dismantle Criminal Window Cleaning Empire
just now
Alleged Crime Group Leader Killed, Two Members Arrested in Isabela
just now
Amnesty International to Launch 2025-26 Human Rights Report in Manila
just now